Ultrastructural changes on clinical isolates of trichophyton rubrum, trichophyton mentagrophytes, and microsporum gypseum caused by solanum chrysotrichum saponin SC-2

Planta Medica

Volumn 75, Issue 14, 2009, Pages 1517-1520

  López Villegas, Edgar Oliver ^a   Herrera Arellano, Armando ^b   De Los Ángeles Martínez Rivera, María ^a   Álvarez, Laura ^c   Cano Nepauseno, Magally ^a   Marquina, Silvia ^c   Rodríguez Tovar, Aída Verónica ^a   Tortoriello, Jaime ^b  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c CENTRO DE INVESTIGACIONES QUÍMICAS   (Mexico)

Author keywords

Microsporum gypseum; Solanaceae; Solanum chrysotrichum; Spirostanic saponin; Trichophyton mentagrophytes; Trichophyton rubrum

Indexed keywords

6ALPHA O BETA DEXTRO XYLOPYRANOSYL (1-3) BETA DEXTRO QUINOVOPYRANOSYL 5ALPHA SPIROSTAN 3BETA OL; PLANT EXTRACT; SAPONIN; SOLANUM CHRYSOTRICHUM EXTRACT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTHRODERMA GYPSEUM; ARTICLE; CELL DEATH; CELL MEMBRANE; CELL ORGANELLE; CELL ULTRASTRUCTURE; CELL WALL; CONTROLLED STUDY; DRUG MECHANISM; FUNGAL CELL CULTURE; FUNGAL MORPHOLOGY; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; MEMBRANE DAMAGE; NONHUMAN; SOLANUM; SOLANUM CHRYSOTRICHUM; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY;

ANTIFUNGAL AGENTS; CELL DEATH; CELL MEMBRANE; CELL WALL; DERMATOMYCOSES; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSPORUM; ORGANELLES; PLANT EXTRACTS; SAPONINS; SOLANUM; TRICHOPHYTON;

ARTHRODERMA BENHAMIAE; ARTHRODERMA GYPSEUM; ARTHRODERMATACEAE; FUNGI; SOLANACEAE; SOLANUM CHRYSOTRICHUM; TINEA PEDIS; TRICHOPHYTON RUBRUM;

EID: 73349087452     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1185810     Document Type: Article

References (21)

1. Degreef H. Clinical forms of dermatophytoses (ringworm infection). Mycopathologia 2008 166 257-265
2. Havlickova B, Czaika V A., Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008 51 (Suppl.4) 2-15
3. Arenas R. Dermatofitosis en México. Rev Iberoam Micol 2002 19 63-67
4. Hernández-Salazar A, Carbajal-Pruneda P, Fernández Martínez R, Arenas R. Dermatofitosis por Trichophyton rubrum. Experiencia de 10 años (19962005) en un servicio de dermatología de un hospital general de la Ciudad de México. Rev Iberoam Micol 2007 24 122-124
5. Herrera-Arellano A, Rodríguez-Soberanes A, Martínez-Rivera M, Martínez-Cruz E, Zamilpa A, Alvarez L, Tortoriello J. Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on tinea pedis: a controlled and randomized clinical trial. Planta Med 2003 69 1-6
6. Seebacher C, Bouchara J P., Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia 2008 166 335-352
7. Manzano-Gayosso P, Méndez-Tovar L J., Hernández- Hernández F, López-Martínez R. La resistencia a los antifúngicos: un problema emergente en México. Gac Med Mex 2008 144 23-26
8. Méndez-Tovar L J., Manzano-Gayosso P, Velásquez- Hernández V, Millán-Chiu B, Hernández-Hernández F, Mondragón-González R, López-Martínez R. Resistencia a compuestos azólicos de aislamientos clínicos de Trichophyton spp. Rev Iberoam Micol 2007 24 320-322
9. Martinez-Rossi N M., Peres N T., Rossi A. Antifungal resistance mechanisms in dermatophytes. Mycopathologia 2008 166 369-383
10. Watanabe S. Present state and future direction of topical antifungals. Nippon Ishinkin Gakkai Zasshi 1999 40 151-155
11. Lesher J L. Oral therapy of common superficial fungal infections of the skin. J Am Acad Dermatol 1999 40 S31-S34
12. de Pauw B E. Is there a need for new antifungal agents? Clin Microbiol Infect 2000 6 23-28
13. Bennett M L., Fleischer A B., Loveless J W., Feldman S R. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr Dermatol 2000 17 304-309
14. Koroishi A M., Foss S R., Cortez D A., Ueda-Nakamura T, Nakamura C V., Dias Filho B P. In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes. J Ethnopharmacol 2008 117 270-277
15. Lozoya X, Navarro V, García M, Zurita M. Solanum chrysotrichum (Schldl.) a plant used in Mexico for the treatment of skin mycosis. J Ethnopharmacol 1992 36 127-132
16. Zamilpa A, Tortoriello J, Navarro V, Delgado G, Alvarez L. Five new steroidal saponins from Solanum chrysotrichum leaves and their antimycotic activity. J Nat Prod 2002 65 1815-1819
17. Herrera-Arellano A, Martínez Rivera M A., Hernández Cruz M, López Villegas E O., Rodríguez Tovar A V., Alvarez Berber L, Marquina-Bahena S, Navarro-García V, Tortoriello J. Mycologic and transmission electron microscopy study of Solanum chrysotrichum saponin SC2 antifungal activity on Candida species of medical significance. Planta Med 2007 73 1568-1573
18. Herrera-Arellano A, Jiménez-Ferrer E, Vega-Pimentel A M., Martínez-Rivera M, Hernández-Hernández M, Zamilpa A, Tortoriello J. Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole. Planta Med 2004 70 483-488
19. Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Martínez-Rivera M A., Rodríguez-Tovar A V., Herrera-Alvarez S, Salas-Andonaegui M L., Nava-Xalpa M Y., Méndez-Salas A, Tortoriello J. Exploratory study on the clinical and mycological effectiveness of an herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection. Planta Med 2009 75 466-471
20. Simons V, Morrissey J P., Latijnhouwers M, Csukai M, Cleaver A, Yarrow C, Osbourn A. Dual effects of plant steroidal alkaloids on Saccharomyces cerevisiae. Antimicrob Agent Chemother 2006 50 2732-2740
21. Bruneton J. Pharmacognosy phytochemistry, medicinal plants, 2ndedition. Paris Lavoisier Publishing 1999 671-719